Ignite Creation Date:
2025-12-25 @ 1:21 AM
Ignite Modification Date:
2026-05-02 @ 9:08 PM
Study NCT ID:
NCT07128693
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-08-19
First Post:
2025-08-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Single-center, Multicohort, Phase II Clinical Study Evaluating the Combination Therapy of Sacituzumab Tirumotecan in Patients With Unresectable, Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma
Sponsor:
Organization: